Eagle Bay Advisors LLC Cytokinetics Inc Transaction History
Eagle Bay Advisors LLC
- $121 Million
- Q2 2025
Shares
3 transactions
Others Institutions Holding CYTK
# of Institutions
373Shares Held
129MCall Options Held
3.27MPut Options Held
1.19M-
T. Rowe Price Investment Management, Inc. Baltimore, MD17.6MShares$604 Million0.37% of portfolio
-
Black Rock Inc. New York, NY14.7MShares$503 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA12MShares$411 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA7.83MShares$269 Million0.05% of portfolio
-
State Street Corp Boston, MA6.37MShares$219 Million0.01% of portfolio
About CYTOKINETICS INC
- Ticker CYTK
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 94,144,096
- Market Cap $3.23B
- Description
- Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...